Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status
- Dadrie F. Baptiste†1, 5,
- Erina L. MacGeorge†2,
- Maria K. Venetis3,
- Ashton Mouton3,
- L. Brooke Friley3, 6,
- Rebekah Pastor3, 7,
- Kristen Hatten3, 8,
- Janaka Lagoo1, 9,
- Susan E. Clare4Email author and
- Monet W. Bowling1, 10Email author
© The Author(s). 2017
Received: 7 September 2016
Accepted: 27 January 2017
Published: 1 February 2017
Despite no demonstrated survival advantage for women at average risk of breast cancer, rates of contralateral prophylactic mastectomy (CPM) continue to increase. Research reveals women with higher socioeconomic status (SES) are more likely to select CPM. This study examines how indicators of SES, age, and disease severity affect CPM motivations.
Patients (N = 113) who underwent CPM at four Indiana University affiliated hospitals completed telephone interviews in 2013. Participants answered questions about 11 CPM motivations and provided demographic information. Responses to motivation items were factor analyzed, resulting in 4 motivational factors: reducing long-term risk, symmetry, avoiding future medical visits, and avoiding treatments.
Across demographic differences, reducing long-term risk was the strongest CPM motivation. Lower income predicted stronger motivation to reduce long-term risk and avoid treatment. Older participants were more motivated to avoid treatment; younger and more-educated patients were more concerned about symmetry. Greater severity of diagnosis predicted avoiding treatments.
Reducing long-term risk is the primary motivation across groups, but there are also notable differences as a function of age, education, income, and disease severity. To stop the trend of increasing CPM, physicians must tailor patient counseling to address motivations that are consistent across patient populations and those that vary between populations.
KeywordsBreast cancer Contralateral prophylactic mastectomy Motivation Socioeconomic
Despite the lack of a demonstrated survival advantage, the rate of contralateral prophylactic mastectomy (CPM) for the treatment of unilateral breast cancer in women without a genetic predisposition for the development of breast cancer continues to increase unabatedly [1–7]. Increasing use of this procedure contradicts expert medical recommendations, such as those of The National Comprehensive Cancer Network; indeed, it has been estimated that fewer than 10% of women with newly diagnosed breast cancer meet the clinical criteria for CPM . Reversing this trend requires that we understand why women are choosing CPM.
A 2011 survey of CPM-related research noted that women’s reasons for electing CPM were poorly understood . Research conducted in the interim indicates that women choosing CPM are not being influenced by the medical evidence demonstrating no survival advantage [8, 10, 11]. Instead, substantial numbers of women believe they are at considerable risk of a new contralateral primary, and CPM improves their likelihood of survival [10, 11]. Even in the extreme case of the diagnosis of ductal carcinoma in situ (DCIS, Stage 0) this holds true. Breast cancer specific survival for women diagnosed with DCIS and treated by breast conservation or unilateral mastectomy is on the order of 99% at 20 years . Nevertheless, SEER data documents an increase in CPM for DCIS patients from 12.7% in 1998 to 36.5% of cases in 2011 . Patients also report seeking CPM to avoid subsequent medical visits and treatments (e.g., surgery, chemotherapy, medications), and to retain/obtain a symmetrical appearance [10, 11, 14–16].
At the same time, it is clear that the choice of CPM is not uniform across groups of women in the United States. Data from the National Cancer Data Base  and the Florida Cancer Data System , show that higher socioeconomic status (SES) and private insurance are positively associated with undergoing CPM. Correspondingly, White women undergo CPM at a rate at least twice that of Black women . These factors may be proxies for access to all forms of medical care, but they also may represent variation in sources of information about cancer, differing levels of concern about body image, or differing risk perceptions [19, 20]. For example, multiple studies have shown that White women are more likely than other racial groups to overestimate their risk of developing breast cancer [21, 22]. Another demographic associated with higher CPM rates is young age at diagnosis [23–25]. The decision of younger patients to avail themselves of CPM has been attributed to the expectation of a long life following the initial diagnosis with a consequently higher lifetime risk of developing another primary breast cancer [15, 23]. Most prior studies of reasons for CPM have focused on small subsets of possible motivations [8, 26], often reporting percentages of patients experiencing particular motivations or concerns . Alternatively, qualitative studies have explored patients verbatim explanations about the factors that influenced them . Such studies have not directly addressed variation in motivations among patients with different socioeconomic and demographic characteristics. To remedy limitations in the existing research and provide additional insights into CPM decision making, this study addresses the following research questions: (1) What personal motivations for seeking CPM are stronger or weaker overall, and (2) to what extent does their importance for women vary as a function of education, employment, income, insurance status, race, age, and disease severity?
This study was approved by the Indiana University Institutional Review Board (IRB-04, protocol number 1210009689; and IRB-03, protocol number 1304011094). All research was carried out in compliance with the Helsinki Declaration.
The literature was consulted in order to create questions that would adequately represent the range of patient motivations for CPM [10, 11, 14–16]. Draft versions of the questionnaire were piloted with four focus groups of five individuals each; one group consisted of lay individuals, one of physicians practicing non-surgical specialties, and two of the focus groups were made up of breast patients with five breast cancer survivors divided between these two groups. Based on their input, the questionnaire was modified by replacing scientific/medical terms with their lay equivalents, and removing what participants considered to be leading questions and questions that elicited a significant emotional response. The questionnaire is provided in Additional file 1.
This study was facilitated by access to patients who underwent CPM at four hospitals in Indianapolis, all of which are teaching institutions within the Indiana University School of Medicine. Wishard Memorial Hospital (now known as The Sidney and Lois Eskenazi Hospital) is a large public safety net hospital, with a patient population approximately equally divided between Black and non-Hispanic White individuals; most are underinsured. IU Health University Hospital is a tertiary referral center at which many patients have private health insurance. IU Health North and IU Health West are community hospitals. The same surgeons staffed the breast surgical oncology clinics at all four hospitals during the period of this study, helping to ensure that surgeon effects on CPM motivations and decisions were relatively constant across the sample.
Potential participants for this study were identified from hospital billing records using the procedure code for bilateral mastectomy during the years 2008–2012. The lists were then curated to identify patients who had undergone CPM (n = 326). Patients’ names, addresses, telephone numbers and the hospitals at which CPM was performed were obtained from the medical health record system. Approximately one-half of the patients were treated at IU Health University Hospital, slightly over a quarter at IU Health North and the remaining patients divided between IU Health West and Wishard. During 2013, these patients received a mailed introductory letter containing study information. Research team members included faculty, residents, and graduate students, all trained in research ethics and study procedures. Team members telephoned participants, obtained their verbal informed consent, and conducted structured interviews using the motivations questionnaire (n = 117) along with obtaining qualitative data that included brief narratives of their breast cancer experience (reported in ). Only 16 patients contacted were recorded as explicitly refusing the interview and information about these patients was not retained. These 16 patients declined participation for a variety of reasons. Some were still undergoing treatment and reported they were too emotionally “raw” to discuss their CPM decisions, some had experienced subsequent disease progression, and others wished not to revisit their illness. Other nonparticipation resulted from inability to reach patients at the phone numbers in their records.
Invasive ductal cancer (n = 31)
Invasive cancer (n = 26)
Ductal carcinoma in situ (n = 23)
Mass/lump (n = 11)
Invasive lobular cancer (n = 9)
Other (n = 13)
Diagnosis dichotomy (n = 113)
Less serious (n = 47)
More serious (n = 66)
Less than 25 K (n = 7)
25–50 K (n = 20)
51–75 K (n = 25)
76–100 K (n = 17)
101 K (n = 30)
Declined to Answer (n = 14)
Income dichotomy (n = 99)
Less than 51 K (n = 27)
51 K + (n = 72)
Private (n = 80)
Medicare/Medicaid (n = 12)
Other (n = 13)
Declined to Answer (n = 7)
Insurance dichotomy (n = 105)
Private (n = 80)
Other (n = 25)
White (n = 99)
Black (n = 12)
Hispanic (n = 2)
White (n = 99)
Minority (n = 14)
Married/partnership (n = 86)
Divorced/separated (n =12)
Single (n = 8)
Widowed (n = 6)
High school or less (n = 22)
Some college (n = 36)
Bachelor’s degree (n = 32)
Graduate degree (n = 21)
Declined to Answer (n = 2)
Education dichotomy (n = 110)
Less than BA (n = 58)
BA+ (n = 53)
Employed (n = 73)
Retired (n = 18)
Homemaker (n = 14)
Unemployed (n = 4)
Other (n = 1)
Declined to Answer (n = 3)
Employment dichotomy (n = 111)
Employed (n = 73)
Unemployed (n = 37)
Age at Diagnosis
Range 22-73, M = 50.29
SD = 12.50
Age dichotomy (n = 112)
Younger than 46 (n = 44)
46 and older (n = 68)
Given the sample size, the variables of interest were dichotomized for analysis. Sample sizes for dichotomized groups are reported in Table 1. Using the dichotomization of Grimmer et al. , patients aged 45 or younger were classified as younger, with patients 46 and above classified as older. Patients who reported their diagnoses as invasive (ductal, lobular, or other) were classified as having more severe diagnoses, whereas patients with other diagnoses (e.g., DCIS, mass/lump, mammogram abnormality) were classified as having less severe diagnoses. Patients were also grouped into less educated (had not attained a bachelor’s degree) and more educated (bachelor’s or higher), and paid or unpaid work. A lower income group was created from patients who indicated that their income was in the categories 0-$25 K or 25 K–50 K; patients in any of the three higher-income categories were similarly grouped together. Underinsured patients were defined as all patients without commercial insurance or HMO coverage. At the Wishard and University Hospitals, such patients were covered by Medicare, Medicaid, or the Wishard Advantage assistance program. Wishard Advantage is funded by taxes from Marion County, which includes metropolitan Indianapolis, and helps provide coverage for patients with limited financial resources who do not qualify for Medicare or Medicaid. Race was classified as minority (Black and Hispanic) or majority (White, non-Hispanic). Because the number of minority participants was small, resulting in problematic statistical power and interpretation, we elected not to pursue our research question with regard to race, and instead treated race as a control variable in the subsequent analyses.
Participants were asked to consider their experience of 11 motivations for undergoing CPM. These were (1) risk reduction—belief that removing both breasts reduces likelihood of cancer coming back, (2) recurrence-opposite—concern that cancer would appear in the opposite breast, (3) survival—belief that removing both breasts increases the chance of long-term survival, (4) surgery—reduce or avoid need for later breast surgeries, (5) symmetry—desire to maintain a symmetrical appearance, (6) recurrence-distant—concern that cancer would appear elsewhere in the body, (7) radiation—desire to reduce or avoid need for radiation treatment, (8) procedures—desire to reduce or avoid procedures such as mammograms and MRIs, (9) chemotherapy—desire to reduce or avoid chemotherapy, (10) physician visits--desire to reduce or avoid future visits to the breast surgeon, oncologist, or hospital, and (11) medications-- desire to reduce or avoid medications that block hormones. Each motivation was assessed with a single-item measure, on a scale from not at all (1) to a very large amount (5). Age at diagnosis and diagnosis were assessed prior to the motivations; race, education, employment, income, and insurance were assessed afterward.
To determine whether the 11 motivation items represented a smaller set of dimensions, the 11 items were subjected to a principal components exploratory factor analyses with varimax rotation, computed in SPSS 23. Four factors were detected (all factor loadings > .76): avoiding treatment, reducing long-term risk, avoiding future visits, and symmetry. The avoiding treatment factor was comprised of items on the desire to reduce or avoid chemotherapy, radiation, and hormone blocking medication (λ = 2.22; α = .83, M = 2.14, SD = 1.28). The reducing long-term risk factor was comprised of items on the desire to avoid opposite breast new primary, risk reduction, and survival (λ = 2.3; α = .85, M = 4.2, SD = 0.91). The avoiding future visits factor was comprised of items on the desire to avoid physician visits and procedures (λ = 1.69; α = .81, M = 2.24, SD = 1.24). The single symmetry item loaded on its own factor (M = 3.42, SD = 1.44). Two items, assessing the recurrence-distant and surgery motivations, did not load onto any factors and consequently were not analyzed further.
Data was analyzed in three stages. The first stage examined the relative strength of CPM motivations for all participants employing paired-sample t-tests. The second stage examined relationships between dichotomized predictor variables and CPM motivations, also using paired sample t-tests. Finally, the third stage utilized hierarchical multiple regression analyses to determine which predictors had effects independent of the others. For all analyses, unless otherwise specified, significance is reported at p < .05.
The first stage of the analysis examined the average endorsement of each motivation in the total sample. There was variation in the extent to which respondents endorsed the 4 motivation factors for CPM, ranging from strongest endorsement for reducing future risk (M = 4.2; 4 = a large amount) to weakest endorsement for avoiding future visits (2.2; 2 = a small amount). A series of paired-sample t tests revealed that the strength of reducing future risk was significantly greater than the other three motivations, and strength of symmetry was significantly stronger than both avoiding treatment and avoiding future visits. The strength of endorsement for avoiding treatment and avoiding future visits was not significantly different.
Mean comparisons of participant demographics among CPM motivations
Patient Dichotomized Demographics
Reducing Long-term Risk
Avoiding Future Visits
Correlations between dichotomized predictors
Regression analysis of patient demographics and disease severity predicting CPM motivations
This study shows statistically significant differences in CPM motivations as a function of age, education, income, and severity of diagnosis, but also shows considerable similarity in the motivations that are most important to women. Across socioeconomic differences, women participating in our study rated reducing future risk (including survival and avoiding a new primary in the non-involved breast) as the most powerful motivation for their decision to elect CPM. This pattern mirrors the results of several other studies showing that women’s foremost goal in choosing CPM is improving their long-term outcomes [8, 11]. The consistency of this motivation across demographic categories underscores a set of interrelated problems. Women perceive substantial risk from a new contralateral primary, even though that risk is objectively low [11, 28–30]. Further, they believe that CPM improves their long-term outcomes even though the medical evidence does not support this belief (except for women with BRCA mutations) . Despite socioeconomic diversity, which is proxy for participation in different communities, exposure to different media, and different experiences with the health care system, breast cancer patients who choose CPM consistently express the same primary, and erroneous, motivation. Correspondingly, this study suggests that CPM patients are not responding rationally to evidence-based recommendations for more conservative treatment—or that their surgeons are not making those recommendations with sufficient strength.
In the context of this similarity, there were some notable differences in CPM motivations as a function of severity of diagnosis, income, age, and education.
Severity of diagnosis
Compared to patients less severe disease, patients with invasive breast cancer were more motivated by avoiding treatment. Although both invasive breast cancers (more severe) and DCIS (less severe) can be treated by breast conservation or mastectomy, only patients with invasive disease will be offered chemotherapy and all of them will undergo some type of lymph node surgery. Patients with invasive disease face the prospect of more treatment over a longer period of time and their rationale for choosing CPM to avoid additional treatment seems to reflect this. Patients treated for DCIS have a relatively short course of treatment and thus their choice of CPM appears to depend more on wanting to avoid a new breast neoplasm than on avoiding treatment.
Controlling for education, employment, and insurance (along with age, diagnosis, and race), lower income predicted stronger motivations for CPM based on both long-term risk reduction and avoiding treatment. Thus, these income effects are not best explained as resulting from knowledge about breast cancer or CPM, or the direct costs of treatment, hospitalization, or surveillance. A survey of the literature reveals a paucity of data on the effects of a subsequent cancer diagnosis, i.e., recurrence or new primary breast cancer, on low income individuals and households. A possible explanation for the effect of income on CPM decision-making is that because lower-income women are essential to the financial stability of their households, they are especially concerned about the indirect costs of a new primary and associated treatments. Lower-income women in paid employment often have no sick leave; indeed, a 2015 report from the Bureau of Labor Statistics estimates that 39% of the private-sector workforce lacks paid sick days . Unpaid work days deprive families of funds for rent, utilities, transportation, food and other critical expenses, and may result in job loss [32, 33]. Even when lower-income women do not work for pay, they often provide crucial domestic labor (including childcare and eldercare) that allows others to work outside the home [34, 35]. Thus, independent of their education, insurance, or employment, low-income women may have personal incentives to avoid time-consuming treatments for a contralateral new primary that will require substantial time away from normal activities for additional treatments. Since there were no questions in our survey specifically directed to concerns regarding lost jobs, lost income, or sick leave, this explanation for the influence of income will have to be directly tested in a future study.
Age and education
Prior studies have noted that concerns about symmetry and the option for reconstruction prompt CPM [11, 23, 36, 37]. Indeed, King and colleagues found that patients were more likely to select CPM instead of other surgical options when they had strong symmetry concerns . In the current study, not only was symmetry motivation the second-strongest, but patients who were younger and had more education more strongly endorsed symmetry as a motivation for CPM. The effect of age is consistent with greater general concern for physical appearance in younger women  and with results recently reported by Tesson and colleagues . McLaren and Kuh’s analysis of data from the Medical Research Council National Survey of Health and Development suggests that appearance esteem is more sensitive to education than to adult occupationally-defined social class . Correspondingly, more highly-educated women may be more concerned about the impact of breast cancer treatment on their physical appearance. Consequently, with both younger and more-educated women, physicians need to address alternatives to CPM with greater attention to appearance-related concerns.
This study exhibits several limitations that should be considered when interpreting our findings and conducting future research. Respondents self-reported their type of breast neoplasm; the acquisition of clinical data regarding the patients’ tumors, stage of disease, receipt of reconstruction, etc. was not a part of the approved protocol. Additionally, we did not inquire as to the respondents’ family history of breast cancer, number of children or desire for future children, or the disease status at the time of the interview. However, in a companion study to this one we did explore the influence of family and friends treated for breast cancer on the decision to undergo CPM . These or other factors might explain greater variance in participants’ motivations than we were able to explain. We also have no data on the patients who we could not reach by telephone. The inability to reach these potential participants may have introduced bias into our sample. Further, our sample included fewer ethnic minority participants than desired; future prospective research efforts should consider collaboration with community leaders/groups to improve participant diversity [41, 42]. We did not specifically inquire as to BRCA 1/2 mutation carrier status, which raises the possibility that there were more patients (other than the four who identified themselves as carriers) that should have been excluded as CPM would have been indicated. Nonetheless, we believe this study adds important information relevant to the CPM debate. Most of the data regarding SES and its impact on the choice of CPM comes from large regional and national databases that tell us who undergoes CPM but not why. By querying women who chose CPM, we have obtained evidence that the “why?” does not differ greatly as a function of SES: patients are making many of the same assumptions about CPM, survival, and new primary, and thus making similar decisions.
In summary, the current study highlights both consistency and variation in motivations for CPM—and points to the complexity of intervening to halt the trend in selecting this procedure. Across socioeconomic variation, women who choose CPM are highly motivated by the desire to reduce overall risk and risk of a new primary, and improve survival. This is not surprising, since many women overestimate the risk of developing contralateral breast cancer [14, 30]. Further, some women understand the relatively small risk of recurrence but nonetheless prize the small reduction in risk afforded by CPM [10, 11]. To help dissuade patients from CPM, physicians must provide careful explanation that the risk of distant metastases from the index lesion is much greater than the likelihood of a second primary breast cancer , and that metastatic disease not a new primary, will be responsible for patient death. There is a relatively robust portfolio of research on the perceived risk of breast cancer as a function of demographic and psychological variables, which has been summarized nicely in a meta-analysis by Katapodi and colleagues  and revisited more recently by Orom et al. . Since statistical probabilities are often difficult for patients to understand, physicians should consider using visual aids that improve understanding of risk (e.g., depictions of frequency of recurrence per 100 or 1000 patients) . Physicians also need to ensure that patients understand the potential adverse effects of CPM . And, they need to help patients reduce the anxiety that contributes to exaggerated perceptions of risk and leads to surgical decisions that will not affect their survival [11, 43, 46]. Women also choose CPM to avoid to avoid breast asymmetry. A symmetrical appearance is an understandable goal, so physicians need to help patients realize that CPM is not necessary to achieve it. Finally, guiding treatment decisions for lower-income women may require that physicians compassionately address the tension between the minimal likelihood of a new primary and the real economic implications if it occurs.
Publication costs were defrayed by generous donations to the “Take my Hand Luncheon” in Lake Geneva, Wisconsin, USA.
Availability of data and materials
The datasets generated and/or analyzed during the current study available from the corresponding author on reasonable request.
Conception and design: DFB. Development of methodology: DFB, ELM, MKV. Acquisition of data: DFB, ELM, MKV, AM, LBF, RP, KH, JL, SEC, MWB. Analysis and interpretation of data: ELM, MKV, SEC. Writing, review, and/or revision of manuscript: ELM, MKV, SEC, MWB. Study supervision: MWB, ELM, MKV, SEC. All authors read and approved the final draft of this manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This study was approved by the Indiana University Institutional Review Board (IRB-04, protocol number 1210009689; and IRB-03, protocol number 1304011094). All research was carried out in compliance with the Helsinki Declaration.
At the time of questionnaire administration, the script introducing the study outlined the voluntary and confidential nature of the study and asked for subjects’ willingness to proceed as a means of implied consent.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Abbey CK, Borowsky AD, Gregg JP, Cardiff RD, Cherry SR. Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography. J Mammary Gland Biol Neoplasia. 2006;11(2):137–49.View ArticlePubMedGoogle Scholar
- Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. J Am Coll Surg. 2014;219(1):19–28.View ArticlePubMedGoogle Scholar
- Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013;36(4):375–80.View ArticlePubMedGoogle Scholar
- Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17(10):2554–62.View ArticlePubMedGoogle Scholar
- Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9.View ArticlePubMedGoogle Scholar
- Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol. 2014;21(10):3231–9.View ArticlePubMedGoogle Scholar
- Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.
- Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy. JAMA surgery. 2014;149:582–9.
- Morrow M. Prophylactic mastectomy of the contralateral breast. Breast. 2011;20 Suppl 3:S108–110.View ArticlePubMedGoogle Scholar
- Rendle KA, Halley MC, May SG, Frosch DL. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy. Qual Health Res. 2015;25(9):1251–9.View ArticlePubMedGoogle Scholar
- Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373–81.View ArticlePubMedPubMed CentralGoogle Scholar
- Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1(7):888–96.View ArticlePubMedGoogle Scholar
- Rutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States. Ann Surg Oncol. 2015;22(7):2378–86.View ArticlePubMedGoogle Scholar
- Portschy PR, Abbott AM, Burke EE, Nzara R, Marmor S, Kuntz KM, Tuttle TM. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study. Ann Surg Oncol. 2015;22:3846–52.
- Khan SA. Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol. 2011;29(16):2132–5.View ArticlePubMedGoogle Scholar
- Goldhirsch A, Gelber S. Breast cancer: why do women opt for contralateral prophylactic mastectomy? Nat Rev Clin Oncol. 2014;11(8):443–4.View ArticlePubMedGoogle Scholar
- Grimmer L, Liederbach E, Velasco J, Pesce C, Wang CH, Yao K. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. J Am Coll Surg. 2015;221(1):187–96.View ArticlePubMedGoogle Scholar
- Yakoub D, Avisar E, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Moffat F, Livingstone A, Franceschi D. Factors associated with contralateral preventive mastectomy. Breast Cancer (Dove Med Press). 2015;7:1–8.Google Scholar
- Viswanath K, Ackerson LK. Race, ethnicity, language, social class, and health communication inequalities: a nationally-representative cross-sectional study. PLoS One. 2011;6(1):e14550.View ArticlePubMedPubMed CentralGoogle Scholar
- Richardson A, Allen JA, Xiao H, Vallone D. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477–93.View ArticlePubMedGoogle Scholar
- Katapodi MC, Lee KA, Facione NC, Dodd MJ. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med. 2004;38(4):388–402.View ArticlePubMedGoogle Scholar
- Orom H, Kiviniemi MT, Shavers VL, Ross L, Underwood 3rd W. Perceived risk for breast cancer and its relationship to mammography in Blacks, Hispanics, and Whites. J Behav Med. 2013;36(5):466–76.View ArticlePubMedGoogle Scholar
- Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010;3(8):1026–34.View ArticleGoogle Scholar
- Tuttle T, Habermann E, Abraham A, Emory T, Virnig B. Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Rev Anticancer Ther. 2007;7(8):1117–22.View ArticlePubMedGoogle Scholar
- Polednak AP. Frequency of prophylactic contralateral mastectomy among breast cancer patients. J Am Coll Surg. 2001;192(6):804–5.View ArticlePubMedGoogle Scholar
- Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, et al. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015;22(12):3809–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Venetis MK, MacGeorge EL, Baptiste DF, Mouton A, Friley LB, Pastor R, Hatten K, Lagoo J, Bowling MW, Clare SE. Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy. Am J Clin Oncol. 2016. [Epub ahead of print]
- Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243–51.View ArticlePubMedGoogle Scholar
- Liu Y, Perez M, Aft RL, Massman K, Robinson E, Myles S, Schootman M, Gillanders WE, Jeffe DB. Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(3):675–80.View ArticlePubMedPubMed CentralGoogle Scholar
- Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18(11):3129–36.View ArticlePubMedGoogle Scholar
- U.S. Department of Labor BoLS. Employee benefits in the United States-March 2015. https://www.bls.gov/news.release/archives/ebs2_07242015.pdf. Accessed 28 Jan 2017.
- Gould E, Filion K, Green A. The Need for Paid Sick Days. In: EPI Briefing Paper. Washington: Economic Policy Institute; 2011.
- Smith T, Kim JG. Paid Sick Days: Attitutes and Experiences. Washington: The National Opinion Research Center; 2010.Google Scholar
- Clawson D, Gerstel N. Unequal Time: Gender, Class, and Family in Employment Schedules. New York: Russell Sage; 2014.Google Scholar
- Conlon C, Timonen V, Carney G, Scharf T. Women (Re) negotiating care across family generations: Intersections of gender and socioeconomic status. Gend Soc. 2014;28(5):729–51.View ArticleGoogle Scholar
- Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6(6):546–52.View ArticlePubMedGoogle Scholar
- King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64.View ArticlePubMedGoogle Scholar
- Tiggemann M. Body image across the adult life span: stability and change. Body Image. 2004;1(1):29–41.View ArticlePubMedGoogle Scholar
- Tesson S, Richards I, Porter DL, Phillips K, Rankin N, Musiello T, Marven M, Butow P. Women’s preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory. Patient Educ Couns. 2016;99(5):814–22.View ArticlePubMedGoogle Scholar
- McLaren L, Kuh D. Women’s body dissatisfaction, social class, and social mobility. Soc Sci Med. 2004;58(9):1575–84.View ArticlePubMedGoogle Scholar
- Bonevski B, Randell M, Paul C, Chapman K, Twyman L, Bryant J, Brozek I, Hughes C. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14:42.View ArticlePubMedPubMed CentralGoogle Scholar
- Doherty EF, MacGeorge EL, Gillig T, Clare SE. Motivations, concerns, and experiences of women who donate normal breast tissue. Cancer Epidemiol Biomarkers Prev. 2015;24(1):105–10.View ArticlePubMedGoogle Scholar
- Katz SJ, Morrow M. Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA. 2013;310(8):793–4.View ArticlePubMedGoogle Scholar
- Garcia-Retamero R, Cokely ET. Communicating Health Risks With Visual Aids. Curr Dir Psychol Sci. 2013;22:392–9.View ArticleGoogle Scholar
- Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18(11):3110–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Bedrosian I, Yao K. Contralateral Prophylactic Mastectomy: Anxiety, Knowledge and Shared Decision Making. Ann Surg Oncol. 2015;22(12):3767–8.View ArticlePubMedGoogle Scholar